Mean percent PASI improvement with bimekizumab in patients with moderate to severe plaque psoriasis: Pooled results from four phase 3/3b trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 5, n. 6, p. s55, 2021. DOI: 10.25251/skin.5.supp.55. Disponível em: https://skin.dermsquared.com/skin/article/view/1406. Acesso em: 17 may. 2025.